Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

1.96USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$1.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,813
52-wk High
$4.56
52-wk Low
$1.49

Chart for

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.92
Market Cap(Mil.): $111.26
Shares Outstanding(Mil.): 57.06
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 79.62 29.53
EPS (TTM): -0.23 -- --
ROI: -745.47 -0.41 13.00
ROE: -917.44 -3.13 14.69

Earnings vs. Estimates